Skip to content
Wenlo
Sign in
← Markets

United Therapeutics Corporation

Martine A Rothblatt (Chairperson & CEO) sells UTHR shares

4UTHRFiled Nov 3, 2026, 4:30 PM ET· Period Nov 2, 2026

AI-generated summary

Chairperson & CEO, Director Martine A Rothblatt exercised 9,500 stock options for 9,500 shares of Common Stock at an average price of $117.76, valued at $1,118,720, and sold 9,500 shares of Common Stock at an average price of $596.22, valued at $5,664,135.93. Following these transactions, the insider indirectly held 324,443 shares of Common Stock by Trust. These transactions were made under a Rule 10b5-1 trading plan adopted on November 7, 2025.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Martine A Rothblatt · Chairperson & CEO, Director

Rule 10b5-1 plan · adopted Nov 7, 2025

DateTransactionSharesPriceValueHeld afterOwnership
Nov 2, 2026M · exercise or conversion of a derivativeFootnotes F1, F2+9,500$117.76$1,118,720.00333,943Indirect (by Trust)
Nov 2, 2026S · open-market saleFootnotes F1, F3, F2−223$593.09$132,258.78333,720Indirect (by Trust)
Nov 2, 2026S · open-market saleFootnotes F1, F4, F2−905$594.03$537,596.88332,815Indirect (by Trust)
Nov 2, 2026S · open-market saleFootnotes F1, F5, F2−1,599$595.15$951,644.05331,216Indirect (by Trust)
Nov 2, 2026S · open-market saleFootnotes F1, F6, F2−2,776$596.11$1,654,806.91328,440Indirect (by Trust)
Nov 2, 2026S · open-market saleFootnotes F1, F7, F2−2,517$597.02$1,502,689.78325,923Indirect (by Trust)
Nov 2, 2026S · open-market saleFootnotes F1, F8, F2−1,280$597.95$765,371.14324,643Indirect (by Trust)
Nov 2, 2026S · open-market saleFootnotes F1, F9, F2−200$598.84$119,768.40324,443Indirect (by Trust)
Nov 2, 2026M · exercise or conversion of a derivativeStock OptionFootnotes F1, F13, F14−9,500$0.00$0.00109,910Indirect (by Trust)
Footnotes
  1. F1 This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
  2. F10 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
  3. F11 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
  4. F12 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
  5. F13 These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
  6. F14 Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
  7. F2 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
  8. F3 This transaction was executed in multiple trades at prices ranging from $592.49 to $593.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  9. F4 This transaction was executed in multiple trades at prices ranging from $593.51 to $594.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  10. F5 This transaction was executed in multiple trades at prices ranging from $594.55 to $595.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  11. F6 This transaction was executed in multiple trades at prices ranging from $595.58 to $596.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  12. F7 This transaction was executed in multiple trades at prices ranging from $596.59 to $597.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  13. F8 This transaction was executed in multiple trades at prices ranging from $597.63 to $598.615. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  14. F9 This transaction was executed in multiple trades at prices ranging from $598.74 to $599.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

More UTHR filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.